Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer


See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 12, Issue:7, July, 2023

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2023.12(7): 107-118
DOI: https://doi.org/10.20546/ijcmas.2023.1207.013


Oral Cholera Vaccine (Shanchol) is Effective to Prevent Cholera: A Message Learnt from a Post Vaccination Diarrhoea Surveillance Study
1ICMR-Regional Medical Research center, Chandrasekharpur, Bhubaneswar, Odisha - 751023, India
2All India Institute of Medical Sciences, Sijua, Patrapada, Bhubaneswar, Odisha - 751019, India
3Institute of Medical Sciences and SUM Hospital, K8 lane 1, Kalinga Nagar, Bhubaneswar,
Odisha - 751003, India
4Institute Veterinary Science and Animal Husbandry, SOA, Deemed to be University, Syampur, Bhubaneswar, Odisha, India
*Corresponding author
Abstract:

A diarrhea surveillance study was conducted after a mass vaccination with a new Oral cholera vaccine Shanchol, in India. During the study period between 2011-2013, a total of 4050 vaccinated, non-vaccinated resident and traveler diarrhoea patients were examined for different etiologial agents. Among the pathogens, toxigenic E. coli (15.15%), V. cholera (3.38%) and rotavirus (29.12%) were found to be main organisms. The isolation frequencies of V. cholera in vaccinated diarrhea patients, in non-vaccinated diarrhea patients in vaccinated area, in non-vaccinated diarrhea patients in neighboring vaccinated area and in non-vaccinated traveler diarrhea patients from other states were 0.72% (4 of 550), 2.3% (12 of 517), 3.7% (109 of 2885) and 12.2% (12 of 98) respectively. The isolation of V. cholerae from vaccinated diarrhea patients is significantly less than the non-vaccinated traveler diarrhea patients which indicate that reduction of cholera among vaccinated people might be due to immunization with Shanchol. Development of herd immunity may be responsible for less isolation of V. cholerae among non-vaccinated residents in vaccinated area compared to non-vaccinated traveler diarrhea patients. It is suggested to vaccinate the vulnerable population using Shanchol to prevent cholera infection in Puri, in other parts of the country and globe.


Keywords: Cholera, Vibrio cholerae, diarrhoea, cholera vaccine, rotavirus, sanitation

Download this article as Download

How to cite this article:

Hemant Kumar Khuntia, Bhagyalaxmi Biswal, Shantanu Kumar Kar, Bhagirathi Dwibedi, Jyostnamayee Sabat, Prasanta Kumar Bramha, Sanghamitra Pati and Anna Salomi Kerketta. 2023. Oral Cholera Vaccine (Shanchol) is Effective to Prevent Cholera: A Message Learnt From A Post Vaccination Diarrhoea Surveillance Study.Int.J.Curr.Microbiol.App.Sci. 12(7): 107-118. doi: https://doi.org/10.20546/ijcmas.2023.1207.013
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations